- 549–620. doi:10.1124/pr.117.015305. PMID 29941461.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
- 549–620. doi:10.1124/pr.117.015305. PMID 29941461.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
- TAAR1, but
bupropion was
found to be inactive.87,88
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
- 549–620. doi:10.1124/pr.117.015305. PMID 29941461.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
- 549–620. doi:10.1124/pr.117.015305. PMID 29941461.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
- 60–71. doi:10.1016/j.tiv.2017.05.010. PMID 28506818.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
- (2): 318–324. doi:10.1002/dta.2494. PMID 30188017.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
-
producing 107.4 ± 2.5% of the
maximal 5-HT effect.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
- 549–620. doi:10.1124/pr.117.015305. PMID 29941461.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...
- 1021/acsptsci.0c00176. PMC 8033608. PMID 33860183.
Simmler LD,
Buchy D,
Chaboz S,
Hoener MC,
Liechti ME (April 2016). "In
Vitro Characterization of Psychoactive...